MAASH: Funding, Investors & Team (Aug 2026)
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein ingredient to its B2B partners.
MAASH has raised $6.8M across 1 funding round on record, the most recent a Seed of $6.8M announced in Aug 2026.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
MAASH Company Profile and Key Stats
Latest funding round on record: Aug 2026.
MAASH Funding Rounds
MAASH Investors
MAASH Founders and Leadership Team
Contact details for the MAASH team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →MAASH Funding Compared to Other Biotechnology Startups
MAASH's latest round of $6.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like MAASH in Biotechnology and Anderlecht
Companies Similar to MAASH
Turning biomass residues into fit-for-purpose microbial fertilizers, biostimulants and biocontrols.
Nyxoah is a health-technology company focused on the development and commercialization of innovative…
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells,…
Confo Therapeutics is a company focused on drug discovery, specifically targeting GPCRs to address medical…
Animab is a biotech company that focuses on developing unique technology to enhance the health of livestock.…
Augustine Therapeutics company is conducting two drug discovery programs in order to discover new generations…
4Tissue is a company focused on research and clinical trials that creates remedies to address the challenges…
Tavira Therapeutics creates an innovative platform to improve the delivery of genes using AAV. By adding…
AgomAb is creating sub-atomic treatments for the recovery of harmed tissues. Their exceptional agonistic…
BioSourcing is developing a New Generation of Biotherapeutics, in particular Monoclonal Antibodies for Global…
MAASH Funding FAQs
What does MAASH do?
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein ingredient to its B2B partners.
How much funding has MAASH raised?
MAASH has raised $6.8M across 1 round on record. The most recent is a Seed of $6.8M announced in Aug 2026.
When did MAASH last raise funding?
MAASH's most recent funding round on record is a Seed of $6.8M, announced in Aug 2026.
Who has invested in MAASH?
Investors on record for MAASH include InvestPro, Bpifrance, Tereos, Nordzucker, Ambria Capital.
Who founded MAASH?
FundedIQ lists Gaspard Gilbert (Co-Founder and Managing Director) at MAASH.
Where is MAASH headquartered?
MAASH is based in Anderlecht, Belgium.
How many employees does MAASH have?
MAASH is in the 1-10 employee band.
When was MAASH founded?
MAASH was founded in 2021.
How does MAASH's funding compare to other Biotechnology startups?
MAASH's latest round of $6.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's MAASH Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for MAASH is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.